Related Experiment Video
Updated: May 30, 2026
10:16
Production and Targeting of Monovalent Quantum Dots
Published on: October 23, 2014
Assembly and targeting of liposomal nanoparticles encapsulating quantum dots
Rajesh Mukthavaram1, Wolf Wrasidlo, David Hall
1Neuro-oncology Program, Moores Cancer Center, University of California, San Diego, USA.
Bioconjugate Chemistry
|July 27, 2011
Summary
This study developed targeted, PEGylated liposomes encapsulating quantum dots (QDs) for enhanced biomedical imaging. These novel QD liposomes show reduced liver uptake and strong tumor targeting, highlighting their preclinical potential.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Materials Science
Background:
- Quantum dots (QDs) offer bright, stable fluorescence for biomedical imaging.
- Biocompatible and rare earth metal QDs are emerging as safer alternatives.
- Reducing QD liver uptake and enhancing signal are key challenges.
Purpose of the Study:
- To encapsulate QDs within targeted, PEGylated liposomes.
- To minimize QD liver accumulation and amplify fluorescence.
- To evaluate targeted QD liposomes in a xenograft tumor model.
Main Methods:
- Developed a novel lipid-QD conjugate for liposome self-assembly around QDs.
- Characterized liposomal structure using size, SEM, and IR spectroscopy.
- Assessed biodistribution and tumor targeting of PEGylated QD liposomes in vivo.
Main Results:
- Liposomal structure and encapsulation were confirmed.
- PEGylated QD liposomes showed rapid clearance from circulation (within 24h).
- Low residual liver labeling and robust tumor targeting were observed.
Conclusions:
- Targeted, PEGylated QD liposomes effectively reduce liver uptake.
- These QD liposomes demonstrate significant potential for preclinical and clinical imaging.
- The developed system enhances QD signal and targeting for biomedical applications.
